Knowledge

2-hydroxy-dATP diphosphatase

Source 📝

336: 321: 403:. The steady state levels of 8-oxoguanine in DNA of several organs including the brain are significantly reduced in hMTH1-Tg over-expressing mice. Conversely, MTH1-null mice exhibit a significantly higher level of 8-oxo-dGTP accumulation than that of the wild type. Over-expression of hMTH1 prevents the age-dependent accumulation of DNA 8-oxoguanine that occurs in wild-type mice. The lower levels of oxidized guanines are associated with greater 2099: 3329: 332:, which is specific to 8-oxoguanine nucleotides. Human MTH1, however, has substrate specificity for a much broader range of oxidatively damaged nucleotides. The mechanism of hMTH1's broad specificity for these oxidized nucleotides is derived from their recognition in the enzyme's substrate binding pocket due to an exchange of protonation state between two nearby aspartate residues. 443:
to other human cells. Because a cancer cell divides much more rapidly than a normal human cell, it is far more in need of an enzyme like MTH1 that prevents fatal mutations during replication. This property of cancer cells could allow for monitoring of cancer treatment efficacy by measuring MTH1 expression. Development of suitable probes for this purpose is currently underway.
451:
older MTH1 inhibitors may be due to off-target cytotoxic effects. After revisiting the experiment, the original authors of this claim found that while the original MTH1 inhibitors in question lead to damaged nucleotides being incorporated into DNA, they demonstrate the others that do not induce toxicity fail to introduce the DNA lesion. Research into this topic is ongoing.
450:
or antiproliferation effects of MTH1 inhibition on cancer cells, even calling into question whether MTH1 truly does serve to remove oxidatively damaged nucleotides from a cell's nucleotide pool. One study of newly discovered MTH1 inhibitors suggests that these anticancer properties exhibited by the
442:
in cancer cells leads to incorporation of 8-oxo-dGTP and other oxidatively damaged nucleotides into the cell's DNA, damaging it and causing cell death. However, cancer cells have also been shown to benefit from use of MTH1. Cells from malignant breast tumors exhibit extreme MTH1 expression compared
1008:
Coskun E, Jaruga P, Jemth AS, Loseva O, Scanlan LD, Tona A, Lowenthal MS, Helleday T, Dizdaroglu M (September 2015). "Addiction to MTH1 protein results in intense expression in human breast cancer tissue as measured by liquid chromatography-isotope-dilution tandem mass spectrometry".
607:
Rudling, Axel; Gustafsson, Robert; Almlöf, Ingrid; Homan, Evert; Scobie, Martin; Warpman Berglund, Ulrika; Helleday, Thomas; Stenmark, Pål; Carlsson, Jens (2017-10-12). "Fragment-Based Discovery and Optimization of Enzyme Inhibitors by Docking of Commercial Chemical Space".
1120:
Petrocchi A, Leo E, Reyna NJ, Hamilton MM, Shi X, Parker CA, Mseeh F, Bardenhagen JP, Leonard P, Cross JB, Huang S, Jiang Y, Cardozo M, Draetta G, Marszalek JR, Toniatti C, Jones P, Lewis RT (March 2016). "Identification of potent and selective MTH1 inhibitors".
1742:
Takahashi M, Maraboeuf F, Sakai Y, Yakushiji H, Mishima M, Shirakawa M, Iwai S, Hayakawa H, Sekiguchi M, Nakabeppu Y (May 2002). "Role of tryptophan residues in the recognition of mutagenic oxidized nucleotides by human antimutator MTH1 protein".
1499:
Furuichi M, Yoshida MC, Oda H, Tajiri T, Nakabeppu Y, Tsuzuki T, Sekiguchi M (December 1994). "Genomic structure and chromosome location of the human mutT homologue gene MTH1 encoding 8-oxo-dGTPase for prevention of A:T to C:G transversion".
200:, also known as oxidized purine nucleoside triphosphatase, or (2'-deoxy) ribonucleoside 5'-triphosphate pyrophosphohydrolase, or Nudix hydrolase 1 (NUDT1), or MutT homolog 1 (MTH1), or 7,8-dihydro-8-oxoguanine triphosphatase) is an 1951:
Bialkowski K, Kasprzak KS (September 2003). "Inhibition of 8-oxo-2'-deoxyguanosine 5'-triphosphate pyrophosphohydrolase (8-oxo-dGTPase) activity of the antimutagenic human MTH1 protein by nucleoside 5'-diphosphates".
473:
has been made available as a chemical probe to academic researchers. However AstraZeneca has found that neither AZ13792138 nor genetic knockdown of MTH1 displays any significant cytotoxicity to cancer cells.
1712:
Topp H, Armbrust S, Lengger C, Schöch G, Davies J, Stichler W, Manz F, Fusch C (June 2002). "Renal excretion of 8-oxo-7,8-dihydro-2(')-deoxyguanosine: degradation rates of RNA and metabolic rate in humans".
1197:
Kettle JG, Alwan H, Bista M, Breed J, Davies NL, Eckersley K, Fillery S, Foote KM, Goodwin L, Jones DR, Käck H, Lau A, Nissink JW, Read J, Scott JS, Taylor B, Walker G, Wissler L, Wylot M (March 2016).
1335: 1981:
Kamiya H, Yakushiji H, Dugué L, Tanimoto M, Pochet S, Nakabeppu Y, Harashima H (February 2004). "Probing the substrate recognition mechanism of the human MTH1 protein by nucleotide analogs".
351:, suggesting that it is involved in the sanitization of nucleotide pools both for nuclear and mitochondrial genomes. In plants, MTH1 has also been shown to enhance resistance to heat- and 1852:
Kennedy CH, Pass HI, Mitchell JB (June 2003). "Expression of human MutT homologue (hMTH1) protein in primary non-small-cell lung carcinomas and histologically normal surrounding tissue".
1772:
Liu Z, Wang LE, Strom SS, Spitz MR, Babaian RJ, DiGiovanni J, Wei Q (March 2003). "Overexpression of hMTH in peripheral lymphocytes and risk of prostate cancer: a case-control analysis".
808:
De Luca G, Ventura I, Sanghez V, Russo MT, Ajmone-Cat MA, Cacci E, Martire A, Popoli P, Falcone G, Michelini F, Crescenzi M, Degan P, Minghetti L, Bignami M, Calamandrei G (August 2013).
851:"MTH1, an oxidized purine nucleoside triphosphatase, suppresses the accumulation of oxidative damage of nucleic acids in the hippocampal microglia during kainate-induced excitotoxicity" 898:
Tsuzuki T, Egashira A, Igarashi H, Iwakuma T, Nakatsuru Y, Tominaga Y, Kawate H, Nakao K, Nakamura K, Ide F, Kura S, Nakabeppu Y, Katsuki M, Ishikawa T, Sekiguchi M (September 2001).
438:. The enzyme's much-studied ability to sanitize a cell's nucleotide pool prevents it from developing mutations, including cancerous ones. Specifically, another study found that MTH1 427:
Studies have suggested that this enzyme plays a role in both preventing the formation of cancer cells and the proliferation of cancer cells. This makes it a topic of interest in
252: 2156: 446:
Disagreement exists concerning MTH1's functionality relative to prevention of DNA damage and cancer. Subsequent studies have had difficulty reproducing previously reported
211:. During DNA repair, the enzyme hydrolyses oxidized purines and prevents their addition onto the DNA chain. As such it has important role in aging and cancer development. 2011: 1093:
Samaranayake GJ, Troccoli CI, Huynh MQ, Win A, Ji D, Kool ET, Rai P (July 2017). "Towards a better understanding of MTH1 as a therapeutic target in RAS-driven cancer ".
957:
Gad H, Koolmeister T, Jemth AS, Eshtad S, Jacques SA, Ström CE, et al. (April 2014). "MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool".
2036: 154: 317:
nucleoside triphosphates, such as 8-oxo-dGTP, 8-oxo-dATP, 2-oxo-dATP, 2-hydroxy-dATP, and 2-hydroxy rATP, to monophosphates, thereby preventing misincorporation.
173: 2098: 459:
MTH1 is a potential drug target to treat cancer, however there are conflicting results regarding the cytotoxicity of MTH1 inhibitors toward cancer cells.
2849: 2149: 2379: 339:
Examples of the protonation state exchange between MTH1 residues Asp-119 and Asp-120 that allows the enzyme to recognize oxidized nucleotides.
2078: 2348: 2142: 3048: 407:. The hMTH1-Tg animals have a significantly longer lifespan than their wild-type littermates. These findings provide a link between 766:"Ectopic expression of the human MutT-type Nudix hydrolase, hMTH1, confers enhanced tolerance to oxidative stress in arabidopsis" 593: 166: 328:
MutT enzymes in non-human organisms often have substrate specificity for certain types of oxidized nucleotides, such as that of
2939: 2019: 713:
Waz S, Nakamura T, Hirata K, Koga-Ogawa Y, Chirifu M, Arimori T, Tamada T, Ikemizu S, Nakabeppu Y, Yamagata Y (February 2017).
1531:"Intracellular localization of 8-oxo-dGTPase in human cells, with special reference to the role of the enzyme in mitochondria" 2934: 371: 269:. The enzyme is used in DNA repair, where it hydrolysis the oxidized purines and prevents their addition onto the DNA chain. 133: 109: 3204: 810:"Prolonged lifespan with enhanced exploratory behavior in mice overexpressing the oxidized nucleoside triphosphatase hMTH1" 715:"Structural and Kinetic Studies of the Human Nudix Hydrolase MTH1 Reveal the Mechanism for Its Broad Substrate Specificity" 2956: 1601:"Multi-forms of human MTH1 polypeptides produced by alternative translation initiation and single nucleotide polymorphism" 1336:"The Helleday Team presents potent MTH1 inhibitor 'Karonudib' and experimentally addresses the non-active MTH1 inhibitors" 370:, have been identified. Additional variants have been observed, but their full-length natures have not been determined. A 3004: 2321: 1566:"Regulation of expression of the human MTH1 gene encoding 8-oxo-dGTPase. Alternative splicing of transcription products" 431:, both as a potential method for healthy cells to prevent cancer and a weakness to target within existing cancer cells. 387:
A mouse model has been studied that over-expresses hMTH1-Tg (NUDT1). The hMTH1-Tg mice express high levels of the hMTH1
551:"Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP, a mutagenic substrate for DNA synthesis" 2926: 1599:
Oda H, Taketomi A, Maruyama R, Itoh R, Nishioka K, Yakushiji H, Suzuki T, Sekiguchi M, Nakabeppu Y (November 1999).
3319: 416: 3189: 3349: 3305: 3292: 3279: 3266: 3253: 3240: 3227: 2985: 2526: 2424: 2249: 2245: 2222: 2195: 2182: 2169: 2071: 1046:"A Chimeric ATP-Linked Nucleotide Enables Luminescence Signaling of Damage Surveillance by MTH1, a Cancer Target" 463: 3199: 127: 3153: 3096: 2540: 2235: 2200: 2173: 2128: 488: 335: 194: 32: 114: 3101: 2910: 2873: 2212: 320: 276: 266: 2640: 2280: 1158:"Novel Class of Potent and Cellularly Active Inhibitors Devalidates MTH1 as Broad-Spectrum Cancer Target" 237: 178: 3122: 3041: 2770: 2678: 2124: 1679:"8-Chloro-dGTP, a hypochlorous acid-modified nucleotide, is hydrolyzed by hMTH1, the human MutT homolog" 434:
Eliminating the MTH1 gene in mice results in over three times more mice developing tumors compared to a
363: 102: 3194: 1529:
Kang D, Nishida J, Iyama A, Nakabeppu Y, Furuichi M, Fujiwara T, Sekiguchi M, Takeshige K (June 1995).
510:"Chromosomal location and some structural features of human clathrin light-chain genes (CLTA and CLTB)" 1883:"An oxidized purine nucleoside triphosphatase, MTH1, suppresses cell death caused by oxidative stress" 2064: 1242:
Warpman Berglund U, Sanjiv K, Gad H, Kalderén C, Koolmeister T, Pham T, et al. (December 2016).
966: 911: 664: 296: 508:
Ponnambalam S, Jackson AP, LeBeau MM, Pravtcheva D, Ruddle FH, Alibert C, Parham P (December 1994).
3359: 3158: 2975: 130: 54: 3091: 2990: 2556: 2134: 1797: 990: 435: 1644:"A molecular basis for the selective recognition of 2-hydroxy-dATP and 8-oxo-dGTP by human MTH1" 3354: 2230: 1998: 1969: 1939: 1904: 1869: 1840: 1789: 1760: 1730: 1700: 1677:
Fujikawa K, Yakushiji H, Nakabeppu Y, Suzuki T, Masuda M, Ohshima H, Kasai H (February 2002).
1665: 1630: 1587: 1552: 1517: 1476: 1435: 1316: 1265: 1221: 1179: 1138: 1075: 1026: 982: 939: 880: 831: 787: 746: 692: 633: 625: 572: 531: 356: 292: 224: 121: 3137: 3132: 3106: 3034: 2620: 2566: 2548: 2414: 2404: 2358: 1990: 1961: 1929: 1894: 1861: 1830: 1822: 1781: 1752: 1722: 1690: 1655: 1642:
Sakai Y, Furuichi M, Takahashi M, Mishima M, Iwai S, Shirakawa M, Nakabeppu Y (March 2002).
1620: 1612: 1577: 1542: 1509: 1466: 1425: 1306: 1296: 1255: 1211: 1169: 1130: 1102: 1065: 1057: 1018: 974: 929: 919: 870: 862: 821: 777: 736: 726: 682: 672: 617: 562: 549:
Sakumi K, Furuichi M, Tsuzuki T, Kakuma T, Kawabata S, Maki H, Sekiguchi M (November 1993).
521: 439: 301: 2433: 1156:
Ellermann M, Eheim A, Rahm F, Viklund J, Guenther J, Andersson M, et al. (July 2017).
90: 3184: 3168: 3081: 2967: 2856: 2670: 2370: 2190: 1881:
Yoshimura D, Sakumi K, Ohno M, Sakai Y, Furuichi M, Iwai S, Nakabeppu Y (September 2003).
428: 367: 1386: 66: 970: 915: 668: 651:
Tchou J, Kasai H, Shibutani S, Chung MH, Laval J, Grollman AP, Nishimura S (June 1991).
37: 3333: 3222: 3163: 2290: 1835: 1811:"A novel mechanism for preventing mutations caused by oxidation of guanine nucleotides" 1810: 1361:"MTH1, A Phase I, Study on Tumors Inhibition, First in Human, First in Class (MASTIFF)" 1311: 1284: 1070: 1045: 875: 850: 741: 714: 288: 149: 1965: 1865: 1756: 1726: 1695: 1678: 1625: 1600: 567: 550: 3343: 3127: 3086: 2834: 2444: 934: 900:"Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase" 899: 687: 652: 412: 1801: 374:
that results in the production of an additional, longer isoform has been described.
3076: 2819: 2792: 2721: 2714: 2697: 2692: 2666: 994: 866: 447: 392: 348: 306: 1412:
Kettle JG, Alwan H, Bista M, Breed J, Davies NL, Eckersley K, et al. (2016).
1360: 1106: 355:-induced oxidative stress, resulting in fewer dead cells and less accumulation of 1471: 1454: 1430: 1413: 1216: 1199: 1022: 849:
Kajitani K, Yamaguchi H, Dan Y, Furuichi M, Kang D, Nakabeppu Y (February 2006).
621: 3300: 3235: 3071: 2915: 1414:"Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival" 1200:"Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival" 594:"Entrez Gene: NUDT1 nudix (nucleoside diphosphate linked moiety X)-type motif 1" 470: 255: 3328: 1174: 1157: 1134: 904:
Proceedings of the National Academy of Sciences of the United States of America
657:
Proceedings of the National Academy of Sciences of the United States of America
653:"8-oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity" 2900: 2589: 1994: 1826: 310: 262: 1616: 1582: 1565: 1547: 1530: 629: 3274: 3248: 2606: 2165: 1260: 1243: 764:
Yoshimura K, Ogawa T, Tsujimura M, Ishikawa K, Shigeoka S (September 2014).
731: 677: 404: 388: 344: 287:
during replication and transcription can cause mutations that may result in
220: 2037:"Call to bioscientists: choose and use your chemicaI probes very carefully" 2002: 1973: 1943: 1916:
Kamiya H, Dugué L, Yakushiji H, Pochet S, Nakabeppu Y, Harashima H (2003).
1908: 1899: 1882: 1873: 1844: 1793: 1764: 1734: 1704: 1669: 1660: 1643: 1634: 1513: 1480: 1439: 1320: 1301: 1269: 1225: 1183: 1142: 1079: 1030: 986: 943: 924: 884: 835: 791: 750: 637: 526: 509: 1934: 1917: 1591: 1556: 1521: 696: 576: 535: 1061: 782: 765: 352: 2107:: Solution structure of the hMTH1, a nucleotide pool sanitization enzyme 978: 197: 78: 3011: 2980: 2758: 2753: 2512: 2502: 2477: 2472: 2207: 1244:"Validation and development of MTH1 inhibitors for treatment of cancer" 826: 809: 469:
A potent and selective MTH1 inhibitor AZ13792138 has been developed by
97: 3287: 3057: 2888: 2530: 2507: 2497: 2467: 2462: 2457: 2452: 2409: 2399: 2394: 2389: 2384: 2353: 2341: 2336: 2331: 2326: 2314: 2309: 2304: 2253: 2018:. American Association for the Advancement of Science. Archived from 1785: 483: 408: 314: 201: 161: 73: 61: 49: 3261: 2944: 2883: 2866: 2861: 2709: 2687: 2653: 2648: 2633: 2611: 2599: 2594: 2584: 2579: 2574: 2299: 2275: 334: 319: 273: 2949: 2905: 2893: 2878: 2844: 2839: 2824: 2807: 2802: 2797: 2785: 2780: 2775: 2765: 2741: 2736: 2731: 2726: 2628: 208: 85: 3030: 2138: 2060: 2999: 2995: 2056: 400: 396: 284: 280: 1285:"MTH1 as a Chemotherapeutic Target: The Elephant in the Room" 462:
Karonudib, an MTH1 inhibitor, is currently being evaluated a
391:
that degrades 8-oxodGTP and 8-oxoGTP and therefore excludes
324:
Example hydrolysis of oxidized nucleotide catalyzed by MTH1
309:
in DNA, the protein encoded by this gene is an enzyme that
3026: 1564:
Oda H, Nakabeppu Y, Furuichi M, Sekiguchi M (July 1997).
1237: 1235: 241: 1367:. U.S. National Institutes of Health. 14 February 2017 3317: 240: 3213: 3177: 3146: 3115: 3064: 2965: 2924: 2664: 2538: 2525: 2490: 2442: 2423: 2369: 2289: 2268: 2261: 2244: 2221: 2181: 366:transcript variants, some of which encode distinct 172: 160: 148: 143: 120: 108: 96: 84: 72: 60: 48: 43: 31: 26: 21: 1455:"MutT Homolog 1 (MTH1): The Silencing of a Target" 246: 1918:"Substrate recognition by the human MTH1 protein" 1809:Ishibashi T, Hayakawa H, Sekiguchi M (May 2003). 1044:Ji D, Beharry AA, Ford JM, Kool ET (July 2016). 305:because of its ability to prevent occurrence of 343:The encoded protein is localized mainly in the 803: 801: 3042: 2150: 2072: 8: 1123:Bioorganic & Medicinal Chemistry Letters 466:clinical trial for safety and tolerability. 3049: 3035: 3027: 2535: 2265: 2258: 2157: 2143: 2135: 2079: 2065: 2057: 708: 706: 140: 2127:at the U.S. National Library of Medicine 1933: 1898: 1834: 1694: 1659: 1624: 1581: 1546: 1470: 1429: 1310: 1300: 1259: 1215: 1173: 1069: 933: 923: 874: 825: 781: 740: 730: 686: 676: 566: 525: 239: 2041:The Institute of Cancer Research, London 1283:Samaranayake GJ, Huynh M, Rai P (2017). 1050:Journal of the American Chemical Society 588: 586: 3324: 2094: 2012:"MTH1: From Hot Topic to Devalidation?" 1715:Archives of Biochemistry and Biophysics 500: 18: 7: 1954:Free Radical Biology & Medicine 1887:The Journal of Biological Chemistry 1854:Free Radical Biology & Medicine 1648:The Journal of Biological Chemistry 1570:The Journal of Biological Chemistry 1535:The Journal of Biological Chemistry 719:The Journal of Biological Chemistry 555:The Journal of Biological Chemistry 247:{\displaystyle \rightleftharpoons } 2043:. The Institute of Cancer Research 1922:Nucleic Acids Research. Supplement 14: 204:that in humans is encoded by the 3327: 2097: 2035:Workman, Paul (10 July 2017). 2016:Science Translational Medicine 1459:Journal of Medicinal Chemistry 1418:Journal of Medicinal Chemistry 1334:Thomas A (21 September 2016). 1204:Journal of Medicinal Chemistry 867:10.1523/jneurosci.4948-05.2006 610:Journal of Medicinal Chemistry 372:single-nucleotide polymorphism 1: 1966:10.1016/S0891-5849(03)00362-9 1866:10.1016/S0891-5849(03)00176-X 1757:10.1016/S0022-2836(02)00163-8 1727:10.1016/S0003-9861(02)00034-6 1696:10.1016/S0014-5793(02)02240-8 1107:10.1158/1538-7445.AM2017-5473 568:10.1016/S0021-9258(19)49494-5 2125:2-hydroxy-dATP+diphosphatase 1983:Journal of Molecular Biology 1745:Journal of Molecular Biology 1472:10.1021/acs.jmedchem.6b00283 1431:10.1021/acs.jmedchem.5b01760 1217:10.1021/acs.jmedchem.5b01760 1023:10.1016/j.dnarep.2015.05.008 622:10.1021/acs.jmedchem.7b01006 191:2-hydroxy-dATP diphosphatase 22:2-hydroxy-dATP diphosphatase 2927:Protein-synthesizing GTPase 2010:Lowe, Derek (7 July 2017). 855:The Journal of Neuroscience 770:Plant & Cell Physiology 3376: 1175:10.1021/acschembio.7b00370 1135:10.1016/j.bmcl.2016.02.026 417:DNA damage theory of aging 3205:Michaelis–Menten kinetics 2986:Guanylate-binding protein 2170:acid anhydride hydrolases 2092: 1995:10.1016/j.jmb.2003.12.060 1827:10.1038/sj.embor.embor838 139: 3097:Diffusion-limited enzyme 2541:Heterotrimeric G protein 2236:Phosphoadenylylsulfatase 2129:Medical Subject Headings 1774:Molecular Carcinogenesis 1583:10.1074/jbc.272.28.17843 1548:10.1074/jbc.270.24.14659 489:8-oxo-dGTP diphosphatase 277:nucleoside triphosphates 267:nucleoside triphosphates 2213:Thiamine-triphosphatase 732:10.1074/jbc.m116.749713 678:10.1073/pnas.88.11.4690 1900:10.1074/jbc.M306201200 1661:10.1074/jbc.M110566200 1617:10.1093/nar/27.22.4335 1605:Nucleic Acids Research 1514:10.1006/geno.1994.1657 1302:10.3390/cancers9050047 925:10.1073/pnas.191086798 527:10.1006/geno.1994.1650 340: 325: 248: 3190:Eadie–Hofstee diagram 3123:Allosteric regulation 2968:Polymerization motors 2679:Rho family of GTPases 1261:10.1093/annonc/mdw429 364:alternatively spliced 338: 323: 249: 3200:Lineweaver–Burk plot 1162:ACS Chemical Biology 1062:10.1021/jacs.6b02895 413:oxidative DNA damage 272:Misincorporation of 238: 2976:dynamin superfamily 1935:10.1093/nass/2.1.85 1393:. AstraZeneca. 2016 1340:Helleday Laboratory 979:10.1038/nature13181 971:2014Natur.508..215G 916:2001PNAS...9811456T 669:1991PNAS...88.4690T 347:, with some in the 3159:Enzyme superfamily 3092:Enzyme promiscuity 1365:ClinicalTrials.gov 1248:Annals of Oncology 827:10.1111/acel.12094 783:10.1093/pcp/pcu083 341: 326: 244: 230:2-hydroxy-dATP + H 3315: 3314: 3024: 3023: 3020: 3019: 2521: 2520: 2486: 2485: 2231:Adenylylsulfatase 2115: 2114: 1254:(12): 2275–2283. 616:(19): 8160–8169. 357:hydrogen peroxide 293:neurodegeneration 254:2-hydroxy-dAMP + 225:chemical reaction 188: 187: 184: 183: 103:metabolic pathway 3367: 3350:Nudix hydrolases 3332: 3331: 3323: 3195:Hanes–Woolf plot 3138:Enzyme activator 3133:Enzyme inhibitor 3107:Enzyme catalysis 3051: 3044: 3037: 3028: 2536: 2266: 2259: 2159: 2152: 2145: 2136: 2101: 2081: 2074: 2067: 2058: 2052: 2050: 2048: 2031: 2029: 2027: 2006: 1977: 1947: 1937: 1912: 1902: 1893:(39): 37965–73. 1877: 1848: 1838: 1805: 1786:10.1002/mc.10108 1768: 1738: 1708: 1698: 1673: 1663: 1638: 1628: 1595: 1585: 1576:(28): 17843–50. 1560: 1550: 1541:(24): 14659–65. 1525: 1485: 1484: 1474: 1453:Papeo G (2016). 1450: 1444: 1443: 1433: 1409: 1403: 1402: 1400: 1398: 1383: 1377: 1376: 1374: 1372: 1357: 1351: 1350: 1348: 1346: 1331: 1325: 1324: 1314: 1304: 1280: 1274: 1273: 1263: 1239: 1230: 1229: 1219: 1194: 1188: 1187: 1177: 1168:(8): 1986–1992. 1153: 1147: 1146: 1117: 1111: 1110: 1090: 1084: 1083: 1073: 1041: 1035: 1034: 1005: 999: 998: 965:(7495): 215–21. 954: 948: 947: 937: 927: 910:(20): 11456–61. 895: 889: 888: 878: 846: 840: 839: 829: 805: 796: 795: 785: 761: 755: 754: 744: 734: 725:(7): 2785–2794. 710: 701: 700: 690: 680: 648: 642: 641: 604: 598: 597: 590: 581: 580: 570: 561:(31): 23524–30. 546: 540: 539: 529: 505: 455:As a drug target 302:Escherichia coli 265:oxidized purine 253: 251: 250: 245: 141: 19: 16:Class of enzymes 3375: 3374: 3370: 3369: 3368: 3366: 3365: 3364: 3340: 3339: 3338: 3326: 3318: 3316: 3311: 3223:Oxidoreductases 3209: 3185:Enzyme kinetics 3173: 3169:List of enzymes 3142: 3111: 3082:Catalytic triad 3060: 3055: 3025: 3016: 2961: 2920: 2671:Ras superfamily 2660: 2644: 2624: 2570: 2560: 2552: 2517: 2482: 2438: 2419: 2365: 2322:Plasma membrane 2285: 2240: 2217: 2191:Pyrophosphatase 2177: 2163: 2121: 2116: 2111: 2108: 2102: 2088: 2085: 2055: 2046: 2044: 2034: 2025: 2023: 2022:on 10 July 2017 2009: 1980: 1950: 1915: 1880: 1860:(11): 1447–57. 1851: 1808: 1771: 1741: 1711: 1689:(1–3): 149–51. 1676: 1654:(10): 8579–87. 1641: 1611:(22): 4335–43. 1598: 1563: 1528: 1498: 1494: 1492:Further reading 1489: 1488: 1452: 1451: 1447: 1411: 1410: 1406: 1396: 1394: 1391:Open Innovation 1385: 1384: 1380: 1370: 1368: 1359: 1358: 1354: 1344: 1342: 1333: 1332: 1328: 1282: 1281: 1277: 1241: 1240: 1233: 1196: 1195: 1191: 1155: 1154: 1150: 1119: 1118: 1114: 1092: 1091: 1087: 1043: 1042: 1038: 1007: 1006: 1002: 956: 955: 951: 897: 896: 892: 848: 847: 843: 807: 806: 799: 763: 762: 758: 712: 711: 704: 650: 649: 645: 606: 605: 601: 592: 591: 584: 548: 547: 543: 507: 506: 502: 497: 480: 457: 429:cancer research 425: 385: 380: 236: 235: 233: 217: 17: 12: 11: 5: 3373: 3371: 3363: 3362: 3357: 3352: 3342: 3341: 3337: 3336: 3313: 3312: 3310: 3309: 3296: 3283: 3270: 3257: 3244: 3231: 3217: 3215: 3211: 3210: 3208: 3207: 3202: 3197: 3192: 3187: 3181: 3179: 3175: 3174: 3172: 3171: 3166: 3161: 3156: 3150: 3148: 3147:Classification 3144: 3143: 3141: 3140: 3135: 3130: 3125: 3119: 3117: 3113: 3112: 3110: 3109: 3104: 3099: 3094: 3089: 3084: 3079: 3074: 3068: 3066: 3062: 3061: 3056: 3054: 3053: 3046: 3039: 3031: 3022: 3021: 3018: 3017: 3015: 3014: 3009: 3008: 3007: 3002: 2993: 2988: 2983: 2972: 2970: 2963: 2962: 2960: 2959: 2954: 2953: 2952: 2947: 2942: 2931: 2929: 2922: 2921: 2919: 2918: 2913: 2908: 2903: 2898: 2897: 2896: 2891: 2886: 2881: 2871: 2870: 2869: 2864: 2854: 2853: 2852: 2847: 2842: 2830: 2829: 2828: 2827: 2822: 2812: 2811: 2810: 2805: 2800: 2790: 2789: 2788: 2783: 2778: 2768: 2763: 2762: 2761: 2756: 2746: 2745: 2744: 2739: 2734: 2729: 2719: 2718: 2717: 2712: 2702: 2701: 2700: 2695: 2690: 2675: 2673: 2662: 2661: 2659: 2658: 2657: 2656: 2651: 2642: 2638: 2637: 2636: 2631: 2622: 2618: 2617: 2616: 2615: 2614: 2604: 2603: 2602: 2597: 2587: 2582: 2577: 2568: 2564: 2563: 2562: 2558: 2550: 2545: 2543: 2533: 2523: 2522: 2519: 2518: 2516: 2515: 2510: 2505: 2500: 2494: 2492: 2488: 2487: 2484: 2483: 2481: 2480: 2475: 2470: 2465: 2460: 2455: 2449: 2447: 2440: 2439: 2437: 2436: 2430: 2428: 2421: 2420: 2418: 2417: 2412: 2407: 2402: 2397: 2392: 2387: 2382: 2376: 2374: 2367: 2366: 2364: 2363: 2362: 2361: 2356: 2346: 2345: 2344: 2339: 2334: 2329: 2319: 2318: 2317: 2312: 2307: 2296: 2294: 2287: 2286: 2284: 2283: 2278: 2272: 2270: 2269:Cu++ (3.6.3.4) 2263: 2256: 2242: 2241: 2239: 2238: 2233: 2227: 2225: 2219: 2218: 2216: 2215: 2210: 2205: 2204: 2203: 2198: 2187: 2185: 2179: 2178: 2164: 2162: 2161: 2154: 2147: 2139: 2133: 2132: 2120: 2119:External links 2117: 2113: 2112: 2110: 2109: 2103: 2096: 2093: 2090: 2089: 2086: 2084: 2083: 2076: 2069: 2061: 2054: 2053: 2032: 2007: 1978: 1960:(6): 595–602. 1948: 1913: 1878: 1849: 1806: 1769: 1739: 1709: 1674: 1639: 1596: 1561: 1526: 1495: 1493: 1490: 1487: 1486: 1445: 1424:(6): 2346–61. 1404: 1378: 1352: 1326: 1275: 1231: 1210:(6): 2346–61. 1189: 1148: 1112: 1085: 1056:(29): 9005–8. 1036: 1000: 949: 890: 861:(6): 1688–98. 841: 820:(4): 695–705. 797: 776:(9): 1534–43. 756: 702: 663:(11): 4690–4. 643: 599: 582: 541: 499: 498: 496: 493: 492: 491: 486: 479: 476: 456: 453: 424: 421: 384: 381: 379: 376: 289:carcinogenesis 259: 258: 243: 231: 223:the following 216: 213: 186: 185: 182: 181: 176: 170: 169: 164: 158: 157: 152: 146: 145: 137: 136: 125: 118: 117: 112: 106: 105: 100: 94: 93: 88: 82: 81: 76: 70: 69: 64: 58: 57: 52: 46: 45: 41: 40: 35: 29: 28: 24: 23: 15: 13: 10: 9: 6: 4: 3: 2: 3372: 3361: 3358: 3356: 3353: 3351: 3348: 3347: 3345: 3335: 3330: 3325: 3321: 3307: 3303: 3302: 3297: 3294: 3290: 3289: 3284: 3281: 3277: 3276: 3271: 3268: 3264: 3263: 3258: 3255: 3251: 3250: 3245: 3242: 3238: 3237: 3232: 3229: 3225: 3224: 3219: 3218: 3216: 3212: 3206: 3203: 3201: 3198: 3196: 3193: 3191: 3188: 3186: 3183: 3182: 3180: 3176: 3170: 3167: 3165: 3164:Enzyme family 3162: 3160: 3157: 3155: 3152: 3151: 3149: 3145: 3139: 3136: 3134: 3131: 3129: 3128:Cooperativity 3126: 3124: 3121: 3120: 3118: 3114: 3108: 3105: 3103: 3100: 3098: 3095: 3093: 3090: 3088: 3087:Oxyanion hole 3085: 3083: 3080: 3078: 3075: 3073: 3070: 3069: 3067: 3063: 3059: 3052: 3047: 3045: 3040: 3038: 3033: 3032: 3029: 3013: 3010: 3006: 3003: 3001: 2997: 2994: 2992: 2989: 2987: 2984: 2982: 2979: 2978: 2977: 2974: 2973: 2971: 2969: 2964: 2958: 2955: 2951: 2948: 2946: 2943: 2941: 2938: 2937: 2936: 2933: 2932: 2930: 2928: 2923: 2917: 2914: 2912: 2909: 2907: 2904: 2902: 2899: 2895: 2892: 2890: 2887: 2885: 2882: 2880: 2877: 2876: 2875: 2872: 2868: 2865: 2863: 2860: 2859: 2858: 2855: 2851: 2848: 2846: 2843: 2841: 2838: 2837: 2836: 2832: 2831: 2826: 2823: 2821: 2818: 2817: 2816: 2813: 2809: 2806: 2804: 2801: 2799: 2796: 2795: 2794: 2791: 2787: 2784: 2782: 2779: 2777: 2774: 2773: 2772: 2769: 2767: 2764: 2760: 2757: 2755: 2752: 2751: 2750: 2747: 2743: 2740: 2738: 2735: 2733: 2730: 2728: 2725: 2724: 2723: 2720: 2716: 2713: 2711: 2708: 2707: 2706: 2703: 2699: 2696: 2694: 2691: 2689: 2686: 2685: 2684: 2680: 2677: 2676: 2674: 2672: 2668: 2663: 2655: 2652: 2650: 2647: 2646: 2645: 2639: 2635: 2632: 2630: 2627: 2626: 2625: 2619: 2613: 2610: 2609: 2608: 2605: 2601: 2598: 2596: 2593: 2592: 2591: 2588: 2586: 2583: 2581: 2578: 2576: 2573: 2572: 2571: 2565: 2561: 2555: 2554: 2553: 2547: 2546: 2544: 2542: 2537: 2534: 2532: 2528: 2524: 2514: 2511: 2509: 2506: 2504: 2501: 2499: 2496: 2495: 2493: 2489: 2479: 2476: 2474: 2471: 2469: 2466: 2464: 2461: 2459: 2456: 2454: 2451: 2450: 2448: 2446: 2445:P-type ATPase 2441: 2435: 2432: 2431: 2429: 2426: 2422: 2416: 2413: 2411: 2408: 2406: 2403: 2401: 2398: 2396: 2393: 2391: 2388: 2386: 2383: 2381: 2378: 2377: 2375: 2372: 2368: 2360: 2357: 2355: 2352: 2351: 2350: 2347: 2343: 2340: 2338: 2335: 2333: 2330: 2328: 2325: 2324: 2323: 2320: 2316: 2313: 2311: 2308: 2306: 2303: 2302: 2301: 2298: 2297: 2295: 2292: 2288: 2282: 2279: 2277: 2274: 2273: 2271: 2267: 2264: 2260: 2257: 2255: 2251: 2247: 2243: 2237: 2234: 2232: 2229: 2228: 2226: 2224: 2220: 2214: 2211: 2209: 2206: 2202: 2199: 2197: 2194: 2193: 2192: 2189: 2188: 2186: 2184: 2180: 2175: 2171: 2167: 2160: 2155: 2153: 2148: 2146: 2141: 2140: 2137: 2130: 2126: 2123: 2122: 2118: 2106: 2100: 2095: 2091: 2082: 2077: 2075: 2070: 2068: 2063: 2062: 2059: 2042: 2038: 2033: 2021: 2017: 2013: 2008: 2004: 2000: 1996: 1992: 1989:(4): 843–50. 1988: 1984: 1979: 1975: 1971: 1967: 1963: 1959: 1955: 1949: 1945: 1941: 1936: 1931: 1927: 1923: 1919: 1914: 1910: 1906: 1901: 1896: 1892: 1888: 1884: 1879: 1875: 1871: 1867: 1863: 1859: 1855: 1850: 1846: 1842: 1837: 1832: 1828: 1824: 1821:(5): 479–83. 1820: 1816: 1812: 1807: 1803: 1799: 1795: 1791: 1787: 1783: 1779: 1775: 1770: 1766: 1762: 1758: 1754: 1751:(1): 129–39. 1750: 1746: 1740: 1736: 1732: 1728: 1724: 1720: 1716: 1710: 1706: 1702: 1697: 1692: 1688: 1684: 1680: 1675: 1671: 1667: 1662: 1657: 1653: 1649: 1645: 1640: 1636: 1632: 1627: 1622: 1618: 1614: 1610: 1606: 1602: 1597: 1593: 1589: 1584: 1579: 1575: 1571: 1567: 1562: 1558: 1554: 1549: 1544: 1540: 1536: 1532: 1527: 1523: 1519: 1515: 1511: 1508:(3): 485–90. 1507: 1503: 1497: 1496: 1491: 1482: 1478: 1473: 1468: 1465:(6): 2343–5. 1464: 1460: 1456: 1449: 1446: 1441: 1437: 1432: 1427: 1423: 1419: 1415: 1408: 1405: 1392: 1388: 1382: 1379: 1366: 1362: 1356: 1353: 1341: 1337: 1330: 1327: 1322: 1318: 1313: 1308: 1303: 1298: 1294: 1290: 1286: 1279: 1276: 1271: 1267: 1262: 1257: 1253: 1249: 1245: 1238: 1236: 1232: 1227: 1223: 1218: 1213: 1209: 1205: 1201: 1193: 1190: 1185: 1181: 1176: 1171: 1167: 1163: 1159: 1152: 1149: 1144: 1140: 1136: 1132: 1129:(6): 1503–7. 1128: 1124: 1116: 1113: 1108: 1104: 1100: 1096: 1089: 1086: 1081: 1077: 1072: 1067: 1063: 1059: 1055: 1051: 1047: 1040: 1037: 1032: 1028: 1024: 1020: 1016: 1012: 1004: 1001: 996: 992: 988: 984: 980: 976: 972: 968: 964: 960: 953: 950: 945: 941: 936: 931: 926: 921: 917: 913: 909: 905: 901: 894: 891: 886: 882: 877: 872: 868: 864: 860: 856: 852: 845: 842: 837: 833: 828: 823: 819: 815: 811: 804: 802: 798: 793: 789: 784: 779: 775: 771: 767: 760: 757: 752: 748: 743: 738: 733: 728: 724: 720: 716: 709: 707: 703: 698: 694: 689: 684: 679: 674: 670: 666: 662: 658: 654: 647: 644: 639: 635: 631: 627: 623: 619: 615: 611: 603: 600: 595: 589: 587: 583: 578: 574: 569: 564: 560: 556: 552: 545: 542: 537: 533: 528: 523: 519: 515: 511: 504: 501: 494: 490: 487: 485: 482: 481: 477: 475: 472: 467: 465: 460: 454: 452: 449: 444: 441: 437: 436:control group 432: 430: 422: 420: 418: 414: 410: 406: 402: 398: 394: 390: 382: 377: 375: 373: 369: 365: 360: 358: 354: 350: 346: 337: 333: 331: 322: 318: 316: 312: 308: 304: 303: 298: 294: 290: 286: 282: 278: 275: 270: 268: 264: 257: 229: 228: 227: 226: 222: 214: 212: 210: 207: 203: 199: 196: 192: 180: 177: 175: 171: 168: 165: 163: 159: 156: 153: 151: 147: 142: 138: 135: 132: 129: 126: 123: 119: 116: 113: 111: 107: 104: 101: 99: 95: 92: 89: 87: 83: 80: 79:NiceZyme view 77: 75: 71: 68: 65: 63: 59: 56: 53: 51: 47: 42: 39: 36: 34: 30: 25: 20: 3301:Translocases 3298: 3285: 3272: 3259: 3246: 3236:Transferases 3233: 3220: 3077:Binding site 2814: 2748: 2704: 2682: 2667:Small GTPase 2281:Wilson/ATP7B 2276:Menkes/ATP7A 2104: 2045:. Retrieved 2040: 2024:. Retrieved 2020:the original 2015: 1986: 1982: 1957: 1953: 1925: 1921: 1890: 1886: 1857: 1853: 1818: 1815:EMBO Reports 1814: 1780:(3): 123–9. 1777: 1773: 1748: 1744: 1718: 1714: 1686: 1683:FEBS Letters 1682: 1651: 1647: 1608: 1604: 1573: 1569: 1538: 1534: 1505: 1501: 1462: 1458: 1448: 1421: 1417: 1407: 1395:. Retrieved 1390: 1387:"AZ13792138" 1381: 1369:. Retrieved 1364: 1355: 1343:. Retrieved 1339: 1329: 1292: 1288: 1278: 1251: 1247: 1207: 1203: 1192: 1165: 1161: 1151: 1126: 1122: 1115: 1101:(13): 5473. 1098: 1094: 1088: 1053: 1049: 1039: 1014: 1010: 1003: 962: 958: 952: 907: 903: 893: 858: 854: 844: 817: 813: 773: 769: 759: 722: 718: 660: 656: 646: 613: 609: 602: 558: 554: 544: 520:(3): 440–4. 517: 513: 503: 468: 461: 458: 445: 433: 426: 393:8-oxoguanine 386: 361: 349:mitochondria 342: 329: 327: 307:8-oxoguanine 300: 271: 260: 219:This enzyme 218: 205: 190: 189: 67:BRENDA entry 3072:Active site 2991:Mitofusin-1 2966:3.6.5.5-6: 2935:Prokaryotic 2087:PDB gallery 1928:(2): 85–6. 1721:(1): 31–7. 471:AstraZeneca 261:The enzyme 256:diphosphate 55:IntEnz view 27:Identifiers 3360:DNA repair 3344:Categories 3275:Isomerases 3249:Hydrolases 3116:Regulation 2957:Eukaryotic 2590:Transducin 2427:(3.6.3.10) 2166:Hydrolases 1095:Cancer Res 1017:: 101–10. 1011:DNA Repair 814:Aging Cell 495:References 440:inhibition 311:hydrolyzes 263:hydrolyses 124:structures 91:KEGG entry 3154:EC number 2925:3.6.5.3: 2665:3.6.5.2: 2607:Gustducin 2539:3.6.5.1: 2373:(3.6.3.9) 2293:(3.6.3.8) 2196:Inorganic 1295:(5): 47. 630:1520-4804 448:cytotoxic 405:longevity 389:hydrolase 345:cytoplasm 313:oxidized 242:⇌ 221:catalyses 44:Databases 3355:EC 3.6.1 3178:Kinetics 3102:Cofactor 3065:Activity 2201:Thiamine 2003:15095864 1974:12957652 1944:12903117 1909:12857738 1874:12757855 1845:12717453 1802:26364277 1794:12619034 1765:12051941 1735:12051680 1705:11852070 1670:11756418 1635:10536140 1502:Genomics 1481:26924380 1440:26878898 1321:28481306 1270:27827301 1226:26878898 1184:28679043 1143:26898335 1080:27413803 1031:26202347 987:24695224 944:11572992 885:16467516 836:23648059 792:24928220 751:28035004 638:28929756 514:Genomics 478:See also 378:Research 368:isoforms 362:Several 353:paraquat 297:isolated 295:. First 274:oxidized 215:Function 198:3.6.1.56 179:proteins 167:articles 155:articles 128:RCSB PDB 38:3.6.1.56 3334:Biology 3288:Ligases 3058:Enzymes 3012:Tubulin 2981:Dynamin 2833:other: 2513:Katanin 2503:Kinesin 2478:ATP13A3 2473:ATP13A2 2208:Apyrase 2047:19 July 2026:19 July 1836:1319193 1592:9211940 1557:7782328 1522:7713500 1397:19 July 1371:19 July 1345:19 July 1312:5447957 1289:Cancers 1071:5500214 995:4468358 967:Bibcode 912:Bibcode 876:6793619 742:5314174 697:2052552 665:Bibcode 577:8226881 536:7713494 464:phase I 330:E. coli 283:and/or 115:profile 98:MetaCyc 3320:Portal 3262:Lyases 2889:ARL13B 2749:RhoBTB 2643:α12/13 2531:GTPase 2508:Myosin 2498:Dynein 2468:ATP12A 2463:ATP11B 2458:ATP10A 2453:ATP8B1 2443:Other 2415:ATP1B4 2410:ATP1B3 2405:ATP1B2 2400:ATP1B1 2395:ATP1A4 2390:ATP1A3 2385:ATP1A2 2380:ATP1A1 2371:Na+/K+ 2359:ATP2C2 2354:ATP2C1 2342:ATP2B4 2337:ATP2B3 2332:ATP2B2 2327:ATP2B1 2315:ATP2A3 2310:ATP2A2 2305:ATP2A1 2254:ATPase 2131:(MeSH) 2001:  1972:  1942:  1907:  1872:  1843:  1833:  1800:  1792:  1763:  1733:  1703:  1668:  1633:  1626:148714 1623:  1590:  1555:  1520:  1479:  1438:  1319:  1309:  1268:  1224:  1182:  1141:  1078:  1068:  1029:  993:  985:  959:Nature 942:  932:  883:  873:  834:  790:  749:  739:  695:  685:  636:  628:  575:  534:  484:NUDT15 423:Cancer 409:ageing 315:purine 202:enzyme 162:PubMed 144:Search 134:PDBsum 74:ExPASy 62:BRENDA 50:IntEnz 33:EC no. 3214:Types 2945:EF-Tu 2884:SAR1B 2867:RAB27 2862:RAB23 2815:RhoDF 2705:RhoUV 2688:CDC42 2683:Cdc42 2669:> 2654:GNA13 2649:GNA12 2634:GNA11 2623:αq/11 2612:GNAT3 2600:GNAT2 2595:GNAT1 2585:GNAI3 2580:GNAI2 2575:GNAI1 2527:3.6.5 2491:3.6.4 2434:ATP4A 2425:H+/K+ 2300:SERCA 2262:3.6.3 2246:3.6.3 2223:3.6.2 2183:3.6.1 1798:S2CID 991:S2CID 935:58751 688:51731 415:(see 395:from 383:Aging 299:from 279:into 206:NUDT1 110:PRIAM 3306:list 3299:EC7 3293:list 3286:EC6 3280:list 3273:EC5 3267:list 3260:EC4 3254:list 3247:EC3 3241:list 3234:EC2 3228:list 3221:EC1 3005:OPA1 2998:and 2950:EF-G 2940:IF-2 2906:Rheb 2894:ARL6 2879:ARF6 2850:NRAS 2845:KRAS 2840:HRAS 2825:RhoD 2820:RhoF 2766:RhoH 2742:RhoG 2727:Rac1 2715:RhoV 2710:RhoU 2693:TC10 2629:GNAQ 2349:SPCA 2176:3.6) 2105:1iry 2049:2017 2028:2017 1999:PMID 1970:PMID 1940:PMID 1905:PMID 1870:PMID 1841:PMID 1790:PMID 1761:PMID 1731:PMID 1701:PMID 1666:PMID 1631:PMID 1588:PMID 1553:PMID 1518:PMID 1477:PMID 1436:PMID 1399:2017 1373:2017 1347:2017 1317:PMID 1266:PMID 1222:PMID 1180:PMID 1139:PMID 1076:PMID 1027:PMID 983:PMID 940:PMID 881:PMID 832:PMID 788:PMID 747:PMID 693:PMID 634:PMID 626:ISSN 573:PMID 532:PMID 411:and 399:and 209:gene 174:NCBI 131:PDBe 86:KEGG 3000:MX2 2996:MX1 2916:RGK 2911:Rap 2901:Ran 2874:Arf 2857:Rab 2835:Ras 2793:Rnd 2771:Rho 2722:Rac 2698:TCL 2559:olf 2291:Ca+ 1991:doi 1987:336 1962:doi 1930:doi 1895:doi 1891:278 1862:doi 1831:PMC 1823:doi 1782:doi 1753:doi 1749:319 1723:doi 1719:402 1691:doi 1687:512 1656:doi 1652:277 1621:PMC 1613:doi 1578:doi 1574:272 1543:doi 1539:270 1510:doi 1467:doi 1426:doi 1307:PMC 1297:doi 1256:doi 1212:doi 1170:doi 1131:doi 1103:doi 1066:PMC 1058:doi 1054:138 1019:doi 975:doi 963:508 930:PMC 920:doi 871:PMC 863:doi 822:doi 778:doi 737:PMC 727:doi 723:292 683:PMC 673:doi 618:doi 563:doi 559:268 522:doi 419:). 401:RNA 397:DNA 291:or 285:RNA 281:DNA 150:PMC 122:PDB 3346:: 2681:: 2569:αi 2551:αs 2529:: 2252:: 2174:EC 2168:: 2039:. 2014:. 1997:. 1985:. 1968:. 1958:35 1956:. 1938:. 1924:. 1920:. 1903:. 1889:. 1885:. 1868:. 1858:34 1856:. 1839:. 1829:. 1817:. 1813:. 1796:. 1788:. 1778:36 1776:. 1759:. 1747:. 1729:. 1717:. 1699:. 1685:. 1681:. 1664:. 1650:. 1646:. 1629:. 1619:. 1609:27 1607:. 1603:. 1586:. 1572:. 1568:. 1551:. 1537:. 1533:. 1516:. 1506:24 1504:. 1475:. 1463:59 1461:. 1457:. 1434:. 1422:59 1420:. 1416:. 1389:. 1363:. 1338:. 1315:. 1305:. 1291:. 1287:. 1264:. 1252:27 1250:. 1246:. 1234:^ 1220:. 1208:59 1206:. 1202:. 1178:. 1166:12 1164:. 1160:. 1137:. 1127:26 1125:. 1099:77 1097:. 1074:. 1064:. 1052:. 1048:. 1025:. 1015:33 1013:. 989:. 981:. 973:. 961:. 938:. 928:. 918:. 908:98 906:. 902:. 879:. 869:. 859:26 857:. 853:. 830:. 818:12 816:. 812:. 800:^ 786:. 774:55 772:. 768:. 745:. 735:. 721:. 717:. 705:^ 691:. 681:. 671:. 661:88 659:. 655:. 632:. 624:. 614:60 612:. 585:^ 571:. 557:. 553:. 530:. 518:24 516:. 512:. 359:. 234:O 195:EC 3322:: 3308:) 3304:( 3295:) 3291:( 3282:) 3278:( 3269:) 3265:( 3256:) 3252:( 3243:) 3239:( 3230:) 3226:( 3050:e 3043:t 3036:v 2808:3 2803:2 2798:1 2786:C 2781:B 2776:A 2759:2 2754:1 2737:3 2732:2 2641:G 2621:G 2567:G 2557:G 2549:G 2250:4 2248:- 2172:( 2158:e 2151:t 2144:v 2080:e 2073:t 2066:v 2051:. 2030:. 2005:. 1993:: 1976:. 1964:: 1946:. 1932:: 1926:2 1911:. 1897:: 1876:. 1864:: 1847:. 1825:: 1819:4 1804:. 1784:: 1767:. 1755:: 1737:. 1725:: 1707:. 1693:: 1672:. 1658:: 1637:. 1615:: 1594:. 1580:: 1559:. 1545:: 1524:. 1512:: 1483:. 1469:: 1442:. 1428:: 1401:. 1375:. 1349:. 1323:. 1299:: 1293:9 1272:. 1258:: 1228:. 1214:: 1186:. 1172:: 1145:. 1133:: 1109:. 1105:: 1082:. 1060:: 1033:. 1021:: 997:. 977:: 969:: 946:. 922:: 914:: 887:. 865:: 838:. 824:: 794:. 780:: 753:. 729:: 699:. 675:: 667:: 640:. 620:: 596:. 579:. 565:: 538:. 524:: 232:2 193:(

Index

EC no.
3.6.1.56
IntEnz
IntEnz view
BRENDA
BRENDA entry
ExPASy
NiceZyme view
KEGG
KEGG entry
MetaCyc
metabolic pathway
PRIAM
profile
PDB
RCSB PDB
PDBe
PDBsum
PMC
articles
PubMed
articles
NCBI
proteins
EC
3.6.1.56
enzyme
gene
catalyses
chemical reaction

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.